Clinical Study

Expressions of CXCL12/CXCR4 in Oral Premalignant and Malignant Lesions

Table 1

Association of CXCL12 and CXCR4 expressions in OLK and OSCC tissues.

HistopathologyTotal cases (%)CXCL12-positive cases (%)CXCL12-negative cases (%)P *

OLK2412 (50%)12 (50%)0.003
 CXCR4-positive cases (%)9 (37.5%)8 (33.3%)1 (4.2%)
 CXCR4-negative cases (%)15 (62.5%)4 (16.7%)11 (45.8%)
OSCC4025 (62.5%)15 (37.5%)0.001
 CXCR4-positive cases (%)24 (60.0%)20 (50.0%)4 (10.0%)
 CXCR4-negative cases (%)16 (40.0%)5 (12.5%)11 (27.5%)

*Chi-square test, relationship between CXCL12 and CXCR4 expressions.